Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N
ACRS.OQ - Aclaris Therapeutics Inc
Aclaris Therapeutics Inc ATI-052 Interim Phase 1a Clinical Trial Results Call
Jan 06, 2026 / 01:00PM GMT
=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good day and thank you for standing by. Welcome to the Clara's ATI 052 clinical trial update conference call. At this time, all participants on a listen-only mode. After the speaker's presentation, there will be a question-and-answer session to ask a question. During the session you will need to press 11 on your telephone. You will then hear automated message advising your hand is raised. Please note that today's conference is being recorded. I will now hand the conference over to your speaker host, Will Roberts, head of communications. Please go ahead.
--------------------------------------------------------------------------------
Unidentified_2 [2]
---------------------------

